| Similar Articles |
|---|
 |
The Motley Fool
November 9, 2009
Dave Mock |
A Big Upgrade for Gilead Sciences The biopharmaceutical company moves up to a five star rating from Motley Fool analysts.   |
The Motley Fool
January 20, 2010
Dave Mock |
A Big Upgrade for Smart Balance A total of 210 Motley Fool analysts have given their opinion on the food-products marketer, with many of them offering analysis and commentary explaining the recent optimism, and raising the stock to a four-star rating. |
The Motley Fool
February 23, 2010
Dave Mock |
A Big Upgrade for Art Technology Group After being stuck for more than a year at no better than a three-star rank, enough top-performing CAPS members have turned bullish on e-commerce software provider Art Technology Group to upgrade it to a more formidable four stars. |
The Motley Fool
September 26, 2011
Brian Orelli |
Closer to Approval, Now Can MELA Find Customers? The restrictions might be too much. The company has been fighting for years to gain Food and Drug Administration approval of its melanoma detection device, MelaFind. |
The Motley Fool
November 3, 2011
Brian Orelli |
FDA Approves! Investors Shrug. Investors just aren't that into MELA Sciences' newly approved melanoma detection device. |
The Motley Fool
September 8, 2011
Brian Orelli |
All Approvals Are Not Created Equal MELA's EU approval for its skin cancer detector MelaFind isn't nearly as important as one stateside would be. |
The Motley Fool
November 19, 2010
Brian Orelli |
Up 95%, but Still Risky as Heck That's an understatement for MELA Sciences. |
The Motley Fool
August 18, 2011
Brian Orelli |
Running the Correct Trial Isn't Enough MELA Sciences' stock is up on claim that their trial meets FDA guidance, but they still need to prove that the device actually works. |
The Motley Fool
July 15, 2008
Brian Orelli |
Will a New Use Help Schering-Plough's Near-Blockbuster Drug? Delaying relapses probably won't be enough to get its Pegintron approved as a treatment for melanoma. |
The Motley Fool
September 30, 2010
Brian Orelli |
Bristol-Myers' Delayed Steal ZymoGenetics price tag looks more reasonable. |
BusinessWeek
May 27, 2010
Pettypiece & Gibson |
Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer." |
The Motley Fool
January 8, 2010
Brian Orelli |
Pfizer's Having a Garage Sale Rather than sending its unwanted drugs to the trash bin, the giant drugmaker is striking deals with its comrades to take them off its hands. |
The Motley Fool
August 21, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Actuate... ArthroCare... Medco Health Solutions... |
The Motley Fool
September 21, 2011 |
One Hot Stock to Avoid Our investing community's latest prime pick to avoid: MELA Sciences. |
The Motley Fool
September 25, 2009 |
2 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs: Cellcom Israel Ltd... China BAK Battery, Inc... |
Chemistry World
November 11, 2015
Maria Burke |
Viral cancer therapy approved in the US The first virus therapy to target cancer has been approved in the US. Its main target will be melanoma, the most aggressive form of skin cancer. |
Nursing Management
June 2009
Zimmerman & Britton |
Prevention Through Vigilance: Malignant Melanoma Management Nurses can play a critical role in the care of patients with melanoma by offering preventive education and support. |
The Motley Fool
April 22, 2009 |
3 Stocks Hitting Low Notes This pharma stock has hit bottom. Is it ready to bounce? Take a look at: Pharmaceutical Product Development... |
American Family Physician
April 1, 2001 |
Melanoma What is melanoma?... Who gets melanoma?... Where do melanomas occur?... What does a melanoma look like?... |
The Motley Fool
January 27, 2009 |
Today's 5-Star Movers A list of today's top-moving stocks from the Motley Fool five-star stock list. |
American Family Physician
November 15, 2000 |
How to Prevent Melanoma Melanoma is a kind of skin cancer. It is sometimes called malignant melanoma. Melanoma is becoming more common every year. This is a very serious kind of skin cancer that can cause death.... |
American Family Physician
July 15, 2005
Rager, Bridgeford & Ollila |
Cutaneous Melanoma: Update on Prevention, Screening, Diagnosis, and Treatment Melanoma is an increasingly common malignancy, and it affects a younger population than most cancers. Selective screening by physicians ultimately may be most effective at preventing the advance of the disease. |
American Family Physician
September 1, 2006 |
Melanoma: A Type of Skin Cancer Melanoma is a type of skin cancer. Most other skin cancers don't spread, but melanoma can spread through the whole body. If it is found early, it can be cured. |
American Family Physician
November 15, 2000
Richard L. Edman & Jonathan T. Wolfe |
Prevention and Early Detection of Malignant Melanoma In addressing the problem of malignant melanoma, family physicians should emphasize primary prevention... |
